Liao C, Lai J, Chen Y, Hsu Y, Wu M, Zheng C
Sci Rep. 2023; 13(1):12867.
PMID: 37553351
PMC: 10409749.
DOI: 10.1038/s41598-023-39913-w.
Alsultan M, Kliea M, Anan M, Abdulkader B, Kazkaz R, Al Sultan A
Ann Med Surg (Lond). 2023; 85(6):2451-2458.
PMID: 37363538
PMC: 10289654.
DOI: 10.1097/MS9.0000000000000632.
Thurlow J, Joshi M, Yan G, Norris K, Agodoa L, Yuan C
Am J Nephrol. 2021; 52(2):98-107.
PMID: 33752206
PMC: 8057343.
DOI: 10.1159/000514550.
Potluri V, Sawinski D, Tam V, Shults J, Cohen J, Wiebe D
J Am Soc Nephrol. 2020; 31(11):2622-2630.
PMID: 32917783
PMC: 7608959.
DOI: 10.1681/ASN.2020030290.
Ng E, Wong P, Kamaruddin A, Lim C, Chan Y
Int J Environ Res Public Health. 2020; 17(14).
PMID: 32708766
PMC: 7400380.
DOI: 10.3390/ijerph17145144.
Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease.
Sampson M, Faria N, Powell J
Nephrol Dial Transplant. 2020; 36(8):1399-1407.
PMID: 32651955
PMC: 8311578.
DOI: 10.1093/ndt/gfaa116.
Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis.
Elsayed M, Morris A, Li X, Browne L, Stack A
Nephrol Dial Transplant. 2020; 35(12):2172-2182.
PMID: 31981353
PMC: 7716812.
DOI: 10.1093/ndt/gfz278.
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability.
King A, Siegel M, He Y, Nie B, Wang J, Koo-McCoy S
Sci Transl Med. 2018; 10(456).
PMID: 30158152
PMC: 6454550.
DOI: 10.1126/scitranslmed.aam6474.
Impact of residual kidney function on hemodialysis adequacy and patient survival.
Wang M, Obi Y, Streja E, Rhee C, Chen J, Hao C
Nephrol Dial Transplant. 2018; 33(10):1823-1831.
PMID: 29688442
PMC: 6888034.
DOI: 10.1093/ndt/gfy060.
Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients: A Multicenter Study in China.
Song K, Zhao D, Wang Y, Wang Y, Sun X, Miao L
Chin Med J (Engl). 2017; 130(8):885-891.
PMID: 28397716
PMC: 5407033.
DOI: 10.4103/0366-6999.204103.
Effects of socioeconomic status on physical and mental health of hemodialysis patients in Japan: differences by age, period, and cohort.
Sugisawa H, Shimizu Y, Kumagai T, Sugisaki H, Ohira S, Shinoda T
Int J Nephrol Renovasc Dis. 2016; 9:171-82.
PMID: 27471405
PMC: 4948840.
DOI: 10.2147/IJNRD.S107031.
Achievement of guideline targets in elderly patients on hemodialysis: a multicenter study.
Dimkovic N, Djukanovic L, Marinkovic J, Djuric Z, Knezevic V, Lazarevic T
Int Urol Nephrol. 2015; 47(9):1555-63.
PMID: 26223198
DOI: 10.1007/s11255-015-1055-4.
Management of hyperphosphataemia in chronic kidney disease-challenges and solutions.
Ketteler M, Wuthrich R, Floege J
Clin Kidney J. 2015; 6(2):128-36.
PMID: 26019840
PMC: 4432434.
DOI: 10.1093/ckj/sfs173.
Renal replacement therapy in Ukraine: epidemiology and international comparisons.
Kolesnyk I, Noordzij M, Kolesnyk M, Kulyzky M, Jager K
Clin Kidney J. 2015; 7(3):330-5.
PMID: 25852905
PMC: 4377756.
DOI: 10.1093/ckj/sfu037.
Improvements in renal replacement therapy practice patterns in estonia.
Kolvald K, Pechter U, Luman M, Ilmoja M, Ots-Rosenberg M
Nephron Extra. 2014; 4(2):108-18.
PMID: 25177339
PMC: 4130824.
DOI: 10.1159/000363349.
Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients.
Hanafusa N, Nomura T, Hasegawa T, Nangaku M
Nephrol Dial Transplant. 2014; 29(12):2316-26.
PMID: 25150218
PMC: 4240181.
DOI: 10.1093/ndt/gfu272.
Current status of maintenance hemodialysis in Beijing, China.
Zuo L, Wang M
Kidney Int Suppl (2011). 2014; 3(2):167-169.
PMID: 25018982
PMC: 4089754.
DOI: 10.1038/kisup.2013.6.
Relative survival of peritoneal dialysis and haemodialysis patients: effect of cohort and mode of dialysis initiation.
Heaf J, Wehberg S
PLoS One. 2014; 9(3):e90119.
PMID: 24614569
PMC: 3948631.
DOI: 10.1371/journal.pone.0090119.
Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence.
Lloret M, Ruiz-Garcia C, DaSilva I, Furlano M, Barreiro Y, Ballarin J
Patient Prefer Adherence. 2013; 7:1147-56.
PMID: 24235818
PMC: 3826937.
DOI: 10.2147/PPA.S31694.
Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis.
Wang S, Alfieri T, Ramakrishnan K, Braunhofer P, Newsome B
Nephrol Dial Transplant. 2013; 29(11):2092-9.
PMID: 24009281
PMC: 4209875.
DOI: 10.1093/ndt/gft280.